IBD 50’s 5 Drug Giants Include Actavis, Gilead

By | May 17, 2014

Scalper1 News

With the market wending its way through correction, now is the time to search for stocks primed to grow in the market’s next leg up. Today’s IBD 50 list of highly rated stocks is an excellent starting point. The computer-generated list ranks U.S. stocks based on key metrics, including recent profit growth and IBD’s Composite Rating, which also measures return on equity, sales growth and profit margins. The list includes five large, Scalper1 News

Scalper1 News